GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Loans Receivable

Amicogen (XKRX:092040) Loans Receivable : ₩0 Mil (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Amicogen Loans Receivable?

Amicogen's Loans Receivable for the quarter that ended in Dec. 2023 was ₩0 Mil.


Amicogen Loans Receivable Historical Data

The historical data trend for Amicogen's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amicogen Loans Receivable Chart

Amicogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Amicogen Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Amicogen Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Amicogen Loans Receivable Related Terms

Thank you for viewing the detailed overview of Amicogen's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Amicogen (XKRX:092040) Business Description

Traded in Other Exchanges
N/A
Address
1259-64, Dongbu-ro, Gyeongsangnam-do, Jinseong-myeon, KOR, 660-852
Amicogen, Inc. is an industrial biotechnology company operating in Korea. It is engaged in development, production and distribution of enzymes, bio new materials and healthcare food. The company's products portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP) and protein A chromatography resins.

Amicogen (XKRX:092040) Headlines

No Headlines